CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma

Title
CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma
Authors
Keywords
-
Journal
MEDICINE
Volume 98, Issue 43, Pages e17572
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-10-24
DOI
10.1097/md.0000000000017572

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now